e-learning
resources
Berlin 2001
Tuesday 25.09.2001
News in inhalation therapy and devices in childhood asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Anti-inflammatory treatment in 5-10-year-old mildly symptomatic children with asthma: can we objectively measure the effect?
H. G. M. Arets, A. W. A. Kamps, H. J. L. Brackel, P. G. H. Mulder, N. A. V. Vermue, C. K. van der Ent (Utrecht, Zwolle, Rotterdam, Zeist, The Netherlands)
Source:
Annual Congress 2001 - News in inhalation therapy and devices in childhood asthma
Session:
News in inhalation therapy and devices in childhood asthma
Session type:
Poster Discussion
Number:
3303
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. G. M. Arets, A. W. A. Kamps, H. J. L. Brackel, P. G. H. Mulder, N. A. V. Vermue, C. K. van der Ent (Utrecht, Zwolle, Rotterdam, Zeist, The Netherlands). Anti-inflammatory treatment in 5-10-year-old mildly symptomatic children with asthma: can we objectively measure the effect?. Eur Respir J 2001; 16: Suppl. 31, 3303
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Long-term efficacy of 1 year anti-inflammatory treatment in paediatric patients with mild persistent asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 379s
Year: 2004
Anti-inflammatory effect of low dose theophylline in school children with bronchial asthma
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013
Treatment of severe childhood asthma: what’s the evidence?
Source: Annual Congress 2005 - Difficult asthma in children
Year: 2005
Induced sputum in children with intermitent and persistent asthma: the effect to treatment
Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Year: 2007
L-carnitine improves the asthma control in children with moderate persistent asthma
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
The oral corticosteroid sparing effect of omalizumab in patients with severe chronic asthma: Is there a difference when you become 12 years old?
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011
Omalizumab in children with severe asthma (SA): Which parameters improve after a 16 week trial?
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010
Mepolizumab for severe eosinophilic asthma: a comparison of efficacy in children, adolescents, and adults
Source: International Congress 2018 – New developments in paediatric asthma
Year: 2018
Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
A new observer independent method to assess therapy response in children with severe asthma based on daily lung function
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
The cost-efficacy of combined anti-inflammatory therapy in the treatment of children in severe persistent asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 134s
Year: 2003
Knemometry assessment of short-term lower leg growth in children with asthma treated with fluticasone propionate/formoterol combination therapy
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015
Physical activity in daily life: A new outcome to evaluate young adult survivors of bronchopulmonary dysplasia?
Source: Annual Congress 2013 –Assessment methods involved in the physiotherapy treatment in different patient populations
Year: 2013
The relationship between asthma and obesity in children: is it a case of over diagnosis?
Source: Annual Congress 2007 - Risk factors for childhood asthma: cohort studies
Year: 2007
Low-level laser therapy as a supplementary treatment in patients with moderate to severe persistent asthma
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013
Late Breaking Abstract - Daily physical activity in patients with severe asthma and the effect of anti-IL5 therapy.
Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies
Year: 2019
One year following a real life experience of omalizumab for moderate to severe persistent allergic asthma in Malta
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
Impact of cough on quality of sleep and effect of anti-tussive treatment in children: An observational study
Source: Annual Congress 2011 - Paediatric respiratory infection: signs, symptoms and sequelae
Year: 2011
Late Breaking Abstract - Daily physical activity in patients with severe eosinophilic asthma and the effect of anti-IL5 therapy.
Source: International Congress 2018 – New pharmacological strategies in airway diseases
Year: 2018
Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment?
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept